-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
On August 25, 2022, the international academic journal Journal of Clinical Investigation published online the latest research paper titled "IL20RB mediates tumoral response to osteoclastic niches and promotes bone metastasis of lung cancer" by Hu Guohong's research group from Shanghai Institute of Nutrition and Health, Chinese Academy of Sciences
Bone is the most frequently metastatic target organ of solid tumors including breast cancer, lung cancer, and prostate cancer, and bone metastases cause fractures, pain, and even death of patients.
Hu Guohong's research group found in the study that under the stimulation of tumor cells, osteoclasts can secrete the cytokine IL19, thereby promoting the proliferation of lung cancer cells expressing the IL19 receptor IL20RB, leading to the occurrence of bone metastasis
Dr.
Paper link: https://doi.